NEC typically exhibits genetic abnormalities that resemble their exocrine counterparts, such as TP53, KRAS, BRAF, or Rb1 genes co‐alterations in TP53 and RB1, whereas the genetic alterations in NET are site‐specific. This evidence concerns the gene RB1 and neuroendocrine carcinoma.